Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Methadone Maintenance Treatment Outcome Study in Taiwan (M0508)

14. august 2012 opdateret af: National Health Research Institutes, Taiwan

Opioid abuse is a complex problem, which not only impacts on the affected individuals' physical and psychological health, but also threatens public security and the productivity of the society. Further, through needle sharing and sexual contacts, injecting drug users (IDUs) have become laden with HIV and HIV related health problems, representing a serious public health threat all over the world. In Taiwan, since the identification of the first HIV-infected IDU in 1987, the incident cases have continued to increase, reaching a height of 2,461 in 2005. In order to contain the epidemics of HIV among IDUs, and to prevent its spread to the population in general, the Center for Disease Control (CDC) collaborated with the Department of Justice to initiate and implement a number of harm reduction programs in 2005. The fact that opioid addiction is officially treated as a health rather than a legal issue itself represents a remarkable milestone in Taiwan. Among these harm reduction programs, including needle and syringe exchange for IDUs as well as substitution treatment approaches for opioid dependence, methadone maintenance treatment (MMT) perhaps represents the most most important and most crucial component. Remarkably, in a relatively short time span, more than 60 MMT programs were established, which enrolled more than 15,000 heroin addicts. This notwithstanding, the overall and differential effectiveness of these MMT service delivery systems, as well as the characteristics of these programs and the patients that might contribute toward treatment response or failure remain largely unknown. Such knowledge base is crucial for establishing standardized and feasible outcome evaluation processes for opioid addicts receiving MMT programs, as well as for the further improvement of the efficacy and effectiveness of these programs, in Taiwan.

In order to address some of these issues, this study adopts a multi-site, prospective clinical follow-up design. It aims at establishing a research network for examining MMT outcome, developing standardized MMT outcome assessment instruments and procedures, and identifying predictors of MMT outcome. The findings may contribute to the better understanding of the characteristics of opioid addicts, the effectiveness of MMT and remaining service needs for opioid addicts in Taiwan.

Studieoversigt

Status

Ukendt

Betingelser

Undersøgelsestype

Observationel

Tilmelding (Forventet)

300

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Miaoli, Taiwan
        • Rekruttering
        • Departments of Psychiatry, Wei-Gong Memorial Hospital
        • Ledende efterforsker:
          • Ming-Lun Liu, MD
        • Kontakt:
          • Ming-Lun Liu, MD
      • Taichung, Taiwan
        • Rekruttering
        • Departments of Psychiatry, China Medical University and Hospital
        • Ledende efterforsker:
          • Chieh-Liang Huang, MD
        • Kontakt:
          • Chieh-Liang Huang, MD
      • Taipei, Taiwan
        • Rekruttering
        • Departments of Psychiatry, Taipei City Hospital Song-De Campus
        • Ledende efterforsker:
          • Lien-Wen Su, MD
        • Kontakt:
          • Lien-Wen Su, MD
      • Taipei, Taiwan
        • Rekruttering
        • Departments of Psychiatry, Taipei City Hospital Yang-Ming Campus
        • Ledende efterforsker:
          • Yih-Hong Yang, MD
        • Underforsker:
          • Yung-Chun Fang, MD
        • Kontakt:
          • Yih-Hong Yang, MD
      • Taipei, Taiwan
        • Rekruttering
        • Departments of Psychiatry, Far-Eastern Memorial Hospital
        • Ledende efterforsker:
          • Chi-Shin Wu, MD
        • Underforsker:
          • Kai-Chi Fang, MD
        • Kontakt:
          • Chi-Shin Wu, MD
      • Taipei County, Taiwan
        • Rekruttering
        • Departments of Psychiatry, En-Chu-Kong Hospital
        • Ledende efterforsker:
          • Li-Nen Lin, MD
        • Underforsker:
          • Yen-Feng Lin, MD
        • Kontakt:
          • Li-Nen Lin, MD
      • Tao-Yuan, Taiwan
        • Rekruttering
        • Departments of Psychiatry, Tao-yuan Psychiatric Center
        • Kontakt:
          • Happy Kuy-Lok Tan, MD, MPH
        • Ledende efterforsker:
          • Happy Kuy-Lok Tan, MD, MPH
        • Underforsker:
          • Sun-Yuan Chou, MD
        • Underforsker:
          • Kuen-Hong Wu, MD

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

heroin-addicted patients who seek help for methadone maintenance treatment

Beskrivelse

Inclusion Criteria:

  • Be 18 years or older.
  • Be fulfilling the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria of opiate dependence.
  • Be agree to and capable of signing informed consent form that has been approved by an Institution Review Board.

Exclusion Criteria:

  • Have ever participated in the study at one of the collaborative hospitals/clinics.
  • Be expecting to discontinue methadone treatment for any reason (leaving the methadone clinic's geographic area, pending legal action, etc.) in the following 3 months.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Heroin-addicted Patients
Heroin-addicted outpatient department (OPD) patients who seek help for methadone maintenance treatment

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. juli 2009

Primær færdiggørelse (Forventet)

1. december 2012

Studieafslutning (Forventet)

1. december 2012

Datoer for studieregistrering

Først indsendt

24. marts 2010

Først indsendt, der opfyldte QC-kriterier

24. marts 2010

Først opslået (Skøn)

25. marts 2010

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

15. august 2012

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

14. august 2012

Sidst verificeret

1. august 2012

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 99A1-PHPP39 (Andet bevillings-/finansieringsnummer: National Health Research Institutes)

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Heroinmisbrug

Abonner